Discover
PFE
Pfizer Inc.
23.88
2600 x 23.97
15500 x 23.99
bid
ask
-
0.20
0.83%
9050 @ 07:41 AM
24.01 +0.13 (0.54%)
| Ytd | -4.10% | |
| 1y | -5.69% |
23.74
day range
24.24
23.11
52 week range
28.75
| Open | 24.15 | Prev Close | 24.08 | Low | 23.74 | High | 24.24 | Mkt Cap | 136.10B |
| Vol | 49.24M | Avg Vol | 39.29M | EPS | 1.31 | P/E | 18.23 | Forward P/E | 8.45 |
| Beta | 0.29 | Short Ratio | 4.74 | Inst. Own | 69.36% | Dividend | 1.72 | Div Yield | 7.14 |
| Ex Div Date | 07-24 | Earning | 08-04 | 50-d Avg | 25.77 | 200-d Avg | 25.86 | 1yr Est | 29.15 |
| Income Statement | |||
| Total Revenue | 14.45B | ||
| Revenues (USD) | 14.45B | ||
| Cost of Revenue | 3.55B | ||
| Gross Profit | 10.90B | ||
| Operating Expenses | 7.73B | ||
| Research and Development Expense | 2.49B | ||
| Selling, General and Administrative Expense | 2.96B | ||
| Operating Income | 3.17B | ||
| Income Tax Expense | 461.00M | ||
| Net Income | 2.69B | ||
| Net Income Common Stock | 2.69B | ||
| Net Income Common Stock (USD) | 2.69B | ||
| Consolidated Income | 2.70B | ||
| Net Income from Discontinued Operations | 13.00M | ||
| Net Income to Non-Controlling Interests | 8.00M | ||
| Earnings per Basic Share | 0.47 | ||
| Earnings per Basic Share (USD) | 0.47 | ||
| Earnings per Diluted Share | 0.47 | ||
| Dividends per Basic Common Share | 0.43 | ||
| Earning Before Interest & Taxes (EBIT) | 3.15B | ||
| Earning Before Interest & Taxes (USD) | 3.15B | ||
| Preferred Dividends Income Statement Impact | 1000.00K | ||
| Weighted Average Shares | 5.69B | ||
| Weighted Average Shares Diluted | 5.73B | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.70B | ||
| Cash and Equivalents (USD) | 1.70B | ||
| Investments | 13.00B | ||
| Investments Current | 11.37B | ||
| Investments Non-Current | 1.63B | ||
| Trade and Non-Trade Receivables | 12.59B | ||
| Current Assets | 42.82B | ||
| Property, Plant & Equipment Net | 19.40B | ||
| Total Assets | 207.62B | ||
| Debt Current | 3.89B | ||
| Total Debt | 64.46B | ||
| Current Liabilities | 34.35B | ||
| Debt Non-Current | 60.57B | ||
| Total Liabilities | 117.21B | ||
| Accumulated Retained Earnings (Deficit) | 117.24B | ||
| Accumulated Other Comprehensive Income | -7.20B | ||
| Shareholders Equity | 90.10B | ||
| Shareholders Equity (USD) | 90.10B | ||
| Assets Non-Current | 164.80B | ||
| Total Debt (USD) | 64.46B | ||
| Goodwill and Intangible Assets | 123.97B | ||
| Inventory | 10.67B | ||
| Liabilities Non-Current | 82.87B | ||
| Trade and Non-Trade Payables | 4.51B | ||
| Tax Assets | 13.55B | ||
| Tax Liabilities | 9.25B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.61B | ||
| Net Cash Flow from Financing | -2.86B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 563.00M | ||
| Capital Expenditure | -436.00M | ||
| Issuance (Repayment) of Debt Securities | -127.00M | ||
| Payment of Dividends & Other Cash Distributions | -2.44B | ||
| Net Cash Flow from Investing | 785.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.20B | ||
| Net Cash Flow from Operations | 2.62B | ||
| Effect of Exchange Rate Changes on Cash | 19.00M | ||
| Share Based Compensation | 272.00M | ||